CCKBR and neuroendocrine neoplasm: The gallbladder hormone-2 (CCK2) receptor is overexpressed in MTC, small cell lung cancer, and other neuroendocrine tumors (Refardt et al., 2021) and is considered a promising new target for NENs therapy.